Boston, Massachusetts 02115

  • Prostate Cancer

Purpose:

The purpose of this study is to develop and evaluate a computer-based decision aid (DA) for use by men considering PSA screening for prostate cancer. Major medical organizations recommend that men discuss the risks and benefits of this test with their physician before making the decision. This educational, interactive DA will help them prepare for that discussion.


Study summary:

Prostate cancer (CaP) is a formidable public health problem in the US and in industrialized countries worldwide. Methods for primary prevention of CaP are unknown. As a result, early detection has become a mainstay of cancer control efforts. However, there is considerable controversy regarding the efficacy of screening in reducing disease-specific mortality. In light of this uncertainty, major medical organizations, including the National Cancer Institute, currently recommend that men discuss the pros and cons of CaP screening and make individualized screening decisions with their health care providers. However, because of constraints on time during medical encounters, it is not always feasible for providers to engage in in-depth discussions regarding the complexities of this issue. Therefore, interventions to promote informed decision-making (IDM) outside of clinical settings are needed. In this study, we propose to: (1) develop an interactive computer-based decision aid (DA) to promote IDM for CaP screening; and (2) conduct a randomized controlled worksite trial to evaluate the impact the DA intervention on employed men’s ability to make informed decisions regarding CaP. This work is designed to be responsive to recent calls for IDM interventions in community settings among diverse populations. If successful, our findings could validate the effectiveness of DAs to promote IDM for CaP and serve as a model for widespread dissemination, thus improving quality of care.


Criteria:

Inclusion Criteria: - Worksites employing at least 100 men in target age group (45-65 years old) Exclusion Criteria: - Worksites with high turnover - Non-English speaking workers - Temporary or contract workers


NCT ID:

NCT00207636


Primary Contact:

Principal Investigator
Jennifer D Allen, PN MPH ScD
Dana-Farber Cancer Institute; Harvard School of Public Health

Jennifer D Allen, PN, MPH, ScD
Phone: 617-632-2269
Email: jennifer_allen@dfci.harvard.edu


Backup Contact:

Email: elizabeth_harden@dfci.harvard.edu
Elizabeth A Harden, BA
Phone: 617-632-2185


Location Contact:

Boston, Massachusetts 02115
United States

Jennifer D Allen, PN MPH PhD
Phone: 617-632-2269
Email: jennifer_allen@dfci.harvard.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: April 07, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.